Roberto Ranza

Anti-Toxocara canis seroreactivity across autoimmune rheumatic diseases with exploratory IgG4 and eosinophil-associated signals in systemic lupus erythematosus: a cross-sectional case-control study

Lara Cardoso Rabello, Correa Miranda, Thayná Souza de Paula, Isadora Aparecida Ferreira Silva et autres

br, us (code pays fourni par la source)

Frequency and characteristics of axial involvement in psoriatic arthritis: results from the International Multicentre AXIS Study

Murat Torğutalp, Raquel Almodóvar, Valderílio Feijó Azevedo, Xenofon Baraliakos et autres

de, es, br, be, ca, gb, us, it, nl, ar, tr, sg, mx, Afrique du Sud, nz, in, au, dk, ro, hk, tw, lb (code pays fourni par la source)

Frequency and characteristics of axial involvement in psoriatic arthritis: results from the International Multicentre AXIS Study

Murat Torğutalp, Raquel Almodóvar, V. F. Azevedo, Xenofon Baraliakos et autres

Tuberculosis incidence in patients treated with secukinumab – a real-world study in Brazil

Felipe Merchan Ferraz Grizzo, Sineida Maria Berbert Ferreira, Maria Victoria Súarez Restrepo, Anber Ancel Tanaka et autres

br (code pays fourni par la source)

Efficacy of risankizumab across GRAPPA domains in psoriatic arthritis: a pooled analysis of patients from the phase 3 KEEPsAKE 1 and 2 studies

Laura C. Coates, Ricardo Blanco, Frank Behrens, Alexis Ogdie et autres

gb, es, de, us, be, br, fr (code pays fourni par la source)

ABS1061 COMPARING THE SAFETY OF ADALIMUMAB AND ETANERCEPT AS THE FIRST BIOLOGIC IN RHEUMATOID ARTHRITIS: A SIMULATED RANDOMIZED CONTROLLED TRIAL USING DATA FROM THE BIOBADABRASIL COHORT

M. Bredemeier, E. Reginatto, M. Silvestri Pauwelz, António P. C. Duarte et autres

br (code pays fourni par la source)

POS1173 ASSESSING THE IMPACT OF THE SMOKING–METHOTREXATE INTERACTION ON THE SAFETY OF ANTI-TNF THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SPONDYLOARTHRITIS

M. Bredemeier, Alice de Moraes Baier, Carolina Vieira Tavares, Ângela Luzia Branco Pinto Duarte et autres

br (code pays fourni par la source)

Association Between Achievement of Clinical Disease Control and Improvement in Patient‐Reported Outcomes and Quality of Life in Patients With Psoriatic Arthritis in the Phase 3 SELECT ‐ PsA 1 and 2 Randomized Controlled Trials

Arthur Kavanaugh, Philip J. Mease, Laure Gossec, Roberto Ranza et autres

au, us, jp, at, fr, br (code pays fourni par la source)

AB0480 EARLY FATIGUE IMPROVEMENT WITH GUSELKUMAB ASSOCIATES WITH LONGER TERM DISEASE CONTROL IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS REPORTING SUBSTANTIAL FATIGUE: POST HOC ANALYSES OF A SUB-POPULATION OF A PHASE 3, RANDOMIZED, CONTROLLED TRIAL OF GUSELKUMAB IN BIOLOGIC-NAÏVE PATIENTS

Natalie J. Shiff, D. Gladman, Xenofon Baraliakos, Michael Starr et autres

Enthesitis and Dactylitis Resolution with Risankizumab for Active Psoriatic Arthritis: Integrated Analysis of the Randomized KEEPsAKE 1 and 2 Trials

Shawn G. Kwatra, Saakshi Khattri, Ahmad Z. Amin, Roberto Ranza et autres

us, br, gb (code pays fourni par la source)

Pan American League of Associations for Rheumatology Recommendations for the Treatment of Psoriatic Arthritis

Daniel G. Fernández‐Ávila, Wilson Bautista‐Molano, María Lorena Brance, G. Ávila et autres

co, ar, py, mx, cr, ve, us, kr, pa, cl, ca, br, uy, ee, pe, ec (code pays fourni par la source)

COMPARING THE SAFETY OF ADALIMUMAB AND ETANERCEPT AS FIRST BIOLOGIC IN RHEUMATOID ARTHRITIS: SIMULATING A RANDOMIZED CONTROLLED TRIAL USING DATA FROM BIOBADABRASIL COHORT

Markus Bredemeier, M. Silvestri Pauwelz, E. Reginatto, Ângela Luzia Branco Pinto Duarte et autres

br (code pays fourni par la source)